Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
NCT Number:
NCT04696029
Phase:
II
Protocol Type:
Treatment
Age Group:
Children
Disease Sites:
Brain and Nervous System
Study Objectives:
For more information about the trial above please contact the study team:
Trial opened at the following institutions: Medical University of South Carolina
Study Documents
(MUSC NetID required for document access)